Lipoprotein Lipase anticorps (C-Term)

N° du produit ABIN1108052

Détail du produit anti-Lipoprotein Lipase anticorps

Antigène: Lipoprotein Lipase (LPL)

Épitope: C-Term

Reactivité: Humain, Boeuf (Vache)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Lipoprotein Lipase est non-conjugé

Application: Western Blotting (WB)

Specificité: This antibody detects Lipoprotein lipase (C-term). No cross reactivity with other proteins.

Réactivité croisée (Details): Species reactivity (tested):Human, rat, mouse, bovine

Purification: Immunogen affinity purified

Immunogène: A synthetic peptide corresponding to a sequence at the C-terminal of human LPL .Remarks: Sequence is different to the related rat sequence by two amino acids.

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Reconstitution: 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

Buffer: 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg NaN3

Agent conservateur: Sodium azide, Thimerosal (Merthiolate)

Précaution d'utilisation: This product contains Sodium azide and Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.

Détails sur Lipoprotein Lipase

Antigène: Lipoprotein Lipase (LPL)

Autre désignation: Lipoprotein Lipase (LPL Produits)

Synonymes: anticorps HDLCQ11, anticorps LIPD, anticorps fb62e04, anticorps fc49b03, anticorps wu:fb62e04, anticorps wu:fc49b03, anticorps LPL, anticorps lipd, anticorps hdlcq11, anticorps lpl, anticorps LOC100223817, anticorps lipoprotein lipase, anticorps LPL, anticorps Lpl, anticorps lpl

Sujet: Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. Lipoprotein lipase has been difficult to purify, and its protein sequence remained undetermined until it could be deduced from the nucleotide sequence of its cDNA. The gene encodes a protein of 475 amino acids that becomes a mature protein of 448 residues after cleavage of a signal peptide. Analysis of the sequence indicated that human lipoprotein lipase, hepatic lipase, and pancreatic lipase are members of a gene family. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion.Synonyms: EC=3.1.1.34, LIPD, LPL

ID gène: 280843

NCBI Accession: NP_001068588

UniProt: P11151

Pathways: Lipid Metabolism